This company listing is no longer active
Otonomy Future Growth
Future criteria checks 0/6
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 21.1% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Otonomy crashes 73% as mid-stage trial for tinnitus candidate fails
Aug 01Otonomy GAAP EPS of -$0.19 beats by $0.01
Jul 25Otonomy: Hearing Loss And Tinnitus Data In 2022
Apr 04Shareholders Will Probably Hold Off On Increasing Otonomy, Inc.'s (NASDAQ:OTIC) CEO Compensation For The Time Being
Jun 16Otonomy shares rise after initiating expansion of early-stage OTO-413 hearing loss trial
Jun 15Is Otonomy (NASDAQ:OTIC) Using Debt In A Risky Way?
Feb 02Otonomy And Its Efforts At Resurrecting Itself
Jan 12Are Institutions Heavily Invested In Otonomy, Inc.'s (NASDAQ:OTIC) Shares?
Dec 11Otonomy (OTIC) Investor Presentation - Slideshow
Dec 02Otonomy issues update for Otividex and OTO-313
Nov 30In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Otonomy has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2022 | N/A | -52 | -47 | -47 | N/A |
6/30/2022 | N/A | -53 | -45 | -44 | N/A |
3/31/2022 | 0 | -53 | -45 | -44 | N/A |
12/31/2021 | 0 | -51 | -43 | -42 | N/A |
9/30/2021 | 0 | -48 | -41 | -41 | N/A |
6/30/2021 | 0 | -46 | -41 | -41 | N/A |
3/31/2021 | 0 | -45 | -39 | -39 | N/A |
12/31/2020 | 0 | -45 | -39 | -39 | N/A |
9/30/2020 | 0 | -45 | -38 | -38 | N/A |
6/30/2020 | 0 | -44 | -38 | -38 | N/A |
3/31/2020 | 1 | -44 | -39 | -39 | N/A |
12/31/2019 | 1 | -45 | -38 | -37 | N/A |
9/30/2019 | 1 | -47 | -40 | -40 | N/A |
6/30/2019 | 1 | -49 | -38 | -38 | N/A |
3/31/2019 | 1 | -51 | -40 | -39 | N/A |
12/31/2018 | 1 | -50 | -39 | -38 | N/A |
9/30/2018 | 1 | -56 | -43 | -42 | N/A |
6/30/2018 | 1 | -65 | -51 | -50 | N/A |
3/31/2018 | 1 | -74 | -58 | -57 | N/A |
12/31/2017 | 1 | -90 | -77 | -75 | N/A |
9/30/2017 | 1 | -98 | -81 | -79 | N/A |
6/30/2017 | 1 | -104 | -89 | -86 | N/A |
3/31/2017 | 1 | -111 | -98 | -95 | N/A |
12/31/2016 | 1 | -111 | -97 | -94 | N/A |
9/30/2016 | 0 | -105 | -93 | -90 | N/A |
6/30/2016 | 0 | -94 | N/A | -80 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if OTIC's forecast earnings growth is above the savings rate (2.1%).
Earnings vs Market: Insufficient data to determine if OTIC's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if OTIC's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if OTIC's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if OTIC's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OTIC's Return on Equity is forecast to be high in 3 years time